Restart Life Sciences Corp.
NMLSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $3 | $13 | $6 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $3 | $13 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$1 | -$2 | -$3 |
| % Margin | – | – | – | – |
| Net Income | $0 | -$1 | -$2 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.014 | -0.083 | -0.18 | -0.24 |
| % Growth | 117.3% | 53.8% | 25% | – |
| Operating Cash Flow | -$0 | -$0 | -$1 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$1 | -$2 |